These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9895216)

  • 1. Maternal administration of superoxide dismutase and catalase in phenytoin teratogenicity.
    Winn LM; Wells PG
    Free Radic Biol Med; 1999 Feb; 26(3-4):266-74. PubMed ID: 9895216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative damage in chemical teratogenesis.
    Wells PG; Kim PM; Laposa RR; Nicol CJ; Parman T; Winn LM
    Mutat Res; 1997 Dec; 396(1-2):65-78. PubMed ID: 9434860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of embryonic glutathione peroxidase activity and phenytoin teratogenicity by dietary deprivation of selenium in CD-1 mice.
    Ozolins TR; Siksay DL; Wells PG
    J Pharmacol Exp Ther; 1996 May; 277(2):945-53. PubMed ID: 8627577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenytoin-initiated DNA oxidation in murine embryo culture, and embryo protection by the antioxidative enzymes superoxide dismutase and catalase: evidence for reactive oxygen species-mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity.
    Winn LM; Wells PG
    Mol Pharmacol; 1995 Jul; 48(1):112-20. PubMed ID: 7623765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for embryonic prostaglandin H synthase-catalyzed bioactivation and reactive oxygen species-mediated oxidation of cellular macromolecules in phenytoin and benzo[a]pyrene teratogenesis.
    Winn LM; Wells PG
    Free Radic Biol Med; 1997; 22(4):607-21. PubMed ID: 9013124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of phenytoin teratogenicity and embryonic covalent binding by acetylsalicylic acid, caffeic acid, and alpha-phenyl-N-t-butylnitrone: implications for bioactivation by prostaglandin synthetase.
    Wells PG; Zubovits JT; Wong ST; Molinari LM; Ali S
    Toxicol Appl Pharmacol; 1989 Feb; 97(2):192-202. PubMed ID: 2493687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of murine phenytoin teratogenicity by the gamma-glutamylcysteine synthetase inhibitor L-buthionine-(S,R)-sulfoximine and by the glutathione depletor diethyl maleate.
    Wong M; Helston LM; Wells PG
    Teratology; 1989 Aug; 40(2):127-41. PubMed ID: 2772848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embryonic catalase protects against ethanol embryopathies in acatalasemic mice and transgenic human catalase-expressing mice in embryo culture.
    Miller-Pinsler L; Wells PG
    Toxicol Appl Pharmacol; 2015 Sep; 287(3):232-9. PubMed ID: 26074427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for lipoxygenase-catalyzed bioactivation of phenytoin to a teratogenic reactive intermediate: in vitro studies using linoleic acid-dependent soybean lipoxygenase, and in vivo studies using pregnant CD-1 mice.
    Yu WK; Wells PG
    Toxicol Appl Pharmacol; 1995 Mar; 131(1):1-12. PubMed ID: 7878664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA oxidation as a potential molecular mechanism mediating drug-induced birth defects: phenytoin and structurally related teratogens initiate the formation of 8-hydroxy-2'-deoxyguanosine in vitro and in vivo in murine maternal hepatic and embryonic tissues.
    Liu L; Wells PG
    Free Radic Biol Med; 1995 Nov; 19(5):639-48. PubMed ID: 8529923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryonic arrhythmia by inhibition of HERG channels: a common hypoxia-related teratogenic mechanism for antiepileptic drugs?
    Azarbayjani F; Danielsson BR
    Epilepsia; 2002 May; 43(5):457-68. PubMed ID: 12027905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embryonic catalase protects against endogenous and phenytoin-enhanced DNA oxidation and embryopathies in acatalasemic and human catalase-expressing mice.
    Abramov JP; Wells PG
    FASEB J; 2011 Jul; 25(7):2188-200. PubMed ID: 21478259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of phenytoin bioactivation and teratogenicity by dietary n-3 fatty acids in mice.
    Kubow S
    Lipids; 1992 Sep; 27(9):721-8. PubMed ID: 1487972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of trimethadione and dimethadione teratogenicity by the cyclooxygenase inhibitor acetylsalicylic acid: a unifying hypothesis for the teratologic effects of hydantoin anticonvulsants and structurally related compounds.
    Wells PG; Nagai MK; Greco GS
    Toxicol Appl Pharmacol; 1989 Mar; 97(3):406-14. PubMed ID: 2609340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo phenytoin-initiated oxidative damage to proteins and lipids in murine maternal hepatic and embryonic tissue organelles: potential molecular targets of chemical teratogenesis.
    Liu L; Wells PG
    Toxicol Appl Pharmacol; 1994 Apr; 125(2):247-55. PubMed ID: 8171432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological studies on the potentiation of phenytoin teratogenicity by acetaminophen.
    Lum JT; Wells PG
    Teratology; 1986 Feb; 33(1):53-72. PubMed ID: 3738810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenytoin covalent binding and embryopathy in mouse embryos co-cultured with maternal hepatocytes from mouse, rat, and rabbit.
    Ozolins TR; Wiley MJ; Wells PG
    Biochem Pharmacol; 1995 Nov; 50(11):1831-40. PubMed ID: 8615862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenytoin-induced cleft palate: evidence for embryonic cardiac bradyarrhythmia due to inhibition of delayed rectifier K+ channels resulting in hypoxia-reoxygenation damage.
    Azarbayjani F; Danielsson BR
    Teratology; 2001 Mar; 63(3):152-60. PubMed ID: 11283972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of N-acetylcysteine on fetal development and on phenytoin teratogenicity in mice.
    Wong M; Wells PG
    Teratog Carcinog Mutagen; 1988; 8(2):65-79. PubMed ID: 2899918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for Ras-dependent signal transduction in phenytoin teratogenicity.
    Winn LM; Wells PG
    Toxicol Appl Pharmacol; 2002 Nov; 184(3):144-52. PubMed ID: 12460742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.